|
 |
David Au, M.D., MPH
VA Puget Sound Health Care System
Adjunct Assistant Professor
Additional
Information
|
| Brian
Custer, MPH, PhD
Affiliate Assistant Professor
Scientist, Epidemiology and Health Policy Research
Blood Systems Research Institute, San Francisco, CA
Additional Information
|
Pete
Fullerton, PhD, RPh
Strategic Pharmacy Innovations
Affiliate Professor
D.S. "Pete"”Fullerton has had a distinguished
career in managed care, teaching and research. From 1993-2003, he
served as Vice President and Assistant Vice President for Regence
Blue Shield, Seattle. In 2000, he received the Blue Cross Blue Shield
Association's highest award for innovative pharmacy programs. In
1998 he was one of the original developers of the drug dossier format
which was later adopted by AMCP in 2000. In addition, he has been
very active in the International Society for Pharmacoeconomics and
Outcomes Research (ISPOR), and has served as a member of the Board
of Directors.
Dr. Fullerton's academic background includes Professor of Pharmacy
(affiliate) - University of Washington; Dean of Pharmacy, University
of Utah; Associate Vice President and Professor of Pharmacy, Oregon
State University.
|
William Hollingworth, PhD
Affiliate Research Assistant Professor
University of Bristol, United Kingdom
Dr Hollingworth trained in Health Economics and Health Services Research at the University of York and the University of Cambridge. Between 1998 and 2002 Dr Hollingworth was a Research Associate with the Department of Public Health and Primary Care at the University of Cambridge. Since 2002, Dr Hollingworth has been a Research Assistant Professor of Radiology at the University of Washington with an adjunct appointment with the Pharmaceutical Outcomes Research & Policy Program. His research interests include: the cost-effectiveness of imaging technologies - diagnostic, therapeutic and patient outcomes; the use of decision analysis to evaluate drugs, devices and clinical guidelines; and the validity and responsiveness of preference based outcome measures. Dr Hollingworth's current research projects focus on the cost-effectiveness of spinal cord stimulators for the treatment of chronic low back pain and the role of injury and illness in the rise of personal bankruptcies. Dr. Hollingworth is now teaching and doing research at the University of Bristol in the Department of Social Medicine.
Additional Information
|
Todd
Lee, PharmD, PhD.
Midwest Center for Health Services and Policy Research
Affiliate Associate Professor
Dr. Lee earned his PhD in Pharmaceutical Outcomes Research and
Policy from the University of Washington and his PharmD from Drake
University. Previously, Dr. Lee was a managed care fellow with Regence
Blue Shield and Premera Blue Cross in Washington state and he worked
as a home care pharmacist. Current areas of research include projects
in chronic obstructive pulmonary disease (COPD), asthma, quality
of life and formulary changes. He has published papers relating
to the health economics of asthma, COPD, and HIV.
Additional
Information
|
Donald
L Patrick, PhD.
Professor and Director of Social and Behavioral Sciences, Department
of Health Services, University of Washington
Adjunct Professor
Donald Patrick has been on the University of Washington faculty
since 1987. He was the first Director of Social and Behavioral Sciences
in the School of Public Health, holding this position from 1987
to 2006. He teaches in the MPH and PhD programs in Health Services.
He publishes widely on outcomes in vulnerable populations, chronic
illness, health disparities, and end-of-life care. He directs the
Biobehavioral Cancer Prevention and Control Training Program funded
by the National Cancer Institute. He teaches Assessing Outcomes
in Health and Medicine. He is a member of the Institute of Medicine.
He was founding president of the International Society for Quality
of Life Research. He is co-convenor of the Quality of Life Methods
Group of the Cochrane Collaboration.
Additional
Information
|
Eric Johnson, MPH, PhD
Affiliate Assistant Professor, Department
of Pharmacy
Dr. Johnson specializes in the design of epidemiologic studies that
evaluate drug safety and describe the outcome of illness. Most of
his research investigates patients with diabetes using population-based
registries and insurance databases. He collaborates with investigators
at the Center for Health Research at Kaiser Permanente Northwest.
Dr. Johnson teaches a graduate course on pharmacoepidemiology and
another on the principles of publishing clinical evidence. He began
his career in epidemiology in 1991 at the U.S. Centers for Disease
Control and Prevention (CDC) where he evaluated blood product safety.
He earned an MPH in Health Services Research at the University of
Washington in 1994 with a concentration in outcomes research. He
earned his PhD in epidemiology in 1999, also at the University of
Washington. Prior to joining the Department of Pharmacy, Dr. Johnson
worked as an epidemiologist for the firm Epidemiology Resources,
Inc. (ERI) in Newton, Massachusetts. He is currently a member of
the International Society of Pharmacoepidemiology (ISPE) and the
American Diabetes Association (ADA).
|
David
H. Smith, PhD
Kaiser-Permanente Center for Health Research
Affiliate Associate Professor
Dr. Smith’s research focus is on the economic evaluation
of medical interventions and pharmacoepidemiology. He is involved
in studies analyzing prescribing behavior, medication adherence,
drug use and outcomes, and FDA funded studies on drug safety. He
is currently leading several industry-funded studies on the natural
history (including cost and consequences) of chronic kidney disease.
He is also leading an RWJ-funded investigation into financial incentives
in the treatment of depression in the primary care setting.
Dr. Smith received his pharmacy degree from the University of Washington
in 1990, completed a residency in General/Clinical Pharmacy, and
worked as a clinical pharmacist in home care for several years.
He received a Master’s in Health Services Administration (M.H.A.)
in 1995, and was awarded a Ph.D. in Pharmacy Outcomes Research from
the University of Washington in 1998. He is Honorary Visiting Fellow
at the University of York, Centre for Health Economics, and is adjunct
assistant professor at the University of Washington School of Pharmacy.
Additional
Information
|
|
|
|
|
|